DOT1L and neoplasm: DOT1L inhibitors 1 and 2 can inhibit cell migration as well as Matrigel invasion of MDA-MB231 by ~50% and 25% (Fig. 2f), respectively, indicating the potential of these compounds to inhibit tumor metastasis.